Funding Details
- Awarder
- Inbox
- Date Award
- November 20, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Cantai Therapeutics develops drug candidates to treat autoimmune and inflammatory disorders by developing cytokine-targeting bispecific antibodies that meaningfully improve the status quo for the millions of patients suffering from immune-mediated and autoimmune diseases.
- Market
- Autoimmune and inflammatory disorders
- Location
-
Philadelphia,
PA,
USA
- Coinvestors
- Agent Capital, Tellus BioVentures
Links